Want to join the conversation?
Medical products company $JNJ said its pharma unit Janssen Biologics BV received approval from the European Commission for SIMPONIÂ® for the treatment of polyarticular juvenile idiopathic arthritis. SIMPONI combined with methotrexate is approved for use in children who weigh at least 40 kg and who have failed previous treatment with MTX.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.